Myeloid & Lymphoid disorders Flashcards
Diffuse Large B-cell lymphoma (DLBCL)
- Most common lymphoma in Western world*
- diffuse proliferation of large neoplastic cells
- 2x size as mature lymphocyte
- ages: all (median late 60s)
- possible translocations: MYC, BCL-2, BCL-6
- express B-cell markers: CD19, CD20, CD22, CD79a, Pax-5
- “B symptoms” common
- prognosis: use anti-CD20 antibodies and multi-agent chemotherapy
Prognostic markers for DLBCL
- international prognostic index IPI
- cell of origin
- double/triple hit lymphoma
most common lymphoma in children
- hodgkin lymphoma
- Burkitt lymphoma
Acute Promyelocytic Leukemia
- Subset of AML
- myeloid cells proliferate but stop maturing when the cell is in the promyelocyte stage
- Translocations: t(15;17); PML-RARA
- responds to therapy with all-trans retinoic acid.
- Treatment: ATRA (disassociates retinoic acid receptor complex and allows cell to continue differentiating)
- PML-RARA activates tissue factor promotor leading to coagulation and increased risk of DIC (dissemenated intravascular coagulation)
- expresses high levels of annexin II activating plasmin (leading to fibrinolysis)
- “butterfly or dumbbell shaped” blasts (bilobed)
Follicular Lymphoma
most common indolent lymphoma (causing patients to present with widespread disease and high stage (III or IV)
- affects predominantly adults (rarely kids)
- densely packed lymphoid follicles (with minimal or no tingible body macrophages) containing small cleaved cells without nucleoli (centrocytes) and larger noncleaved cells with round to oval nuclei and multiple nucleoli (centroblasts)
- positive B cell markers: CD19, CD20, bcl-6, CD10, Bcl-2
- Translocation: t(14;18) causing rearrangement of BCL2 gene leading to over expression of Bcl-2 protein preventing apoptosis
Burkitt Lymphoma
aggressive (high-grade) B-cell lymphoma that is most common in children
- translocation: t(8;14) in 75% of cases
- t(2;8) t(8;22)
- common in AIDS patients (CNS involvement common)
- common where malaria is endemic
- endemic BL = Ebstein-Bar virus present (95%)
- endemic BL = presents with jaw and orbital bone tumors (60%)
- Sporadic BL = presents with abdominal mass
- “Starry Sky” morphology: tingible bodies (histiocytes) in sky of dark neoplastic lymphocytes; cells uniform in size and shape w/ 4-5 nucleoli
- positive B-cell markers: CD19, CD20, CD22, CD79a, CD10, Bcl-6
- NEGATIVE: Bcl-2 and TdT
Ebstein Bar Virus
infects lymphoid cells (B cells) by binding to the receptor for complement C3d (CD21)
- causes Infectious mononucleosis
- can cause Burkitt Lymphoma
Mantle Cell Lymphoma
low-grade non-Hodgkin lymphoma of B-cell neoplasm composed of monomorphous small-medium cells w/ irregular nuclei
- median age of 65–70 years
- mainly affects men
- patients present with advanced disease (stage III or IV)
Symptoms: lymphadenopathy, hepatosplenomagaly, bone marrow involvement, lymphocytosis, intestinal polyposis of any part of the GI tract
- proliferation may be in diffuse, nodular, or expansion of mantle zone
- scattered histiocytes with pink cytoplasm = common
Morphologic variants: Blastoid; Pleomorphic; small round lymphocytes; monocytoid differentiation
Positive B-cell markers: CD5, CD43, CD19, CD20, CD22, CD79a
NEGATIVE: CD23, CD10
Translocation: t(11;14)
- Positive for Cyclin D1 which induces cell growth
Marginal Zone B-cell Lymphomas
low-grade, B-cell, non-Hodgkin lymphoma that arises from the marginal zone of extranodal lymphoid follicles
3 types:
- mucosa-associated lymphoid tissue (MALT)
- nodal
- splenic
MALT lymphoma is the most common (usually in the stomach or small intestine) w/ median age: 61
- usually a history of chronic inflammation and autoimmune states: Helicobacter Pylori infection, Sjorgen syndrome, Hashimoto throiditis
- indolent clinical course w/ tendency to stay localized
- patients present usually at Stage I or II
Positive B-cell markers: CD19, CD20, CD22, CD79a
NEGATIVE: CD5, CD10, CD23, Blc-6, Cyclin D1
Classical Hodgkin Lymphoma
- arises in lymph nodes (common in cervical region)
- neoplastic tissues contain Hodgkin and Reed-Sternberg cells (HRS) residing in an infiltrate of inflammatory cells
- bimodal age curve: peak at 15-35 years and at 60 years
- higher incidence with history of infectious mononucleosis
- patients present: enlarged lymph nodes; mediastinal mass (60%); B symptoms (40%)
- associated with EBV infection and HIV infection
Morphology: lymph nodes have “fish flesh appearance”
Positive B-cell markers: CD30, CD15 (85%) - CD20 and CD79a positive in a third of patients
NEGATIVE: CD45
Reed-Sternberg cells’ morphology in cHL
Large and binucleate with prominent eosnophilic nucleolus
Hodgkin cells’ morphology in cHL
Mononuclear or multilobated large cells
B-Cell Chronic Lymphocytic Leukemia
low-grade, non-Hodgkin, B-cell lymphoma
- lymphoproliferative neoplasm of small mature appearing lymphocytes
- affects mainly adults (median age: 65)
- male predominance
- most common chronic leukemia in western world
- patient presents: fatigue, fever, night sweats, weight loss, autoimmune hemolytic anemia, decreased platelets, lymphadenopathy, infections, hepatosplenomegaly
- blood smear shows lymphosytosis
- lymphocytes are small with clumped chromatin and little cytoplasm
- lymph nodes show pale proliferation centers
- positive B-cell markers: CD19, CD20, CD22, CD79a
- co-express CD5 and CD23
- NEGATIVE: CD10 and Cyclin D1*
B-cell markers
CD19; CD22; CD20; CD21; CD79a; CD38; CD138; CD10; CD23
T cell lineage and NK cell markers
CD1alpha; CD2; CD3; CD5; CD7; CD4; CD8; CD16; CD56; CD57
immature lymphoid tissue marker
TdT (terminal deoxynucleotidyltransferase)
HLA-DR
CD34
Germinal center lymphocytes
are of B-lineage
- express: CD19, CD20
- co-express: bcl-6 and CD10
- Negative for: bcl-2*
Reactive Lymphoid Hyperplasia (RLH)
enlargement of lymph nodes/lymphoid organs due to extensive proliferation of cellular compartments
- unknown etiology
- common in children
- morphologic patterns seen in RLH include: follicular, sinusoidal, diffuse, and mixed
- positive B-cell markers: CD19, CD20
- co-express: bcl-6 and CD10
- NEGATIVE: bcl-2*